Recent Finacing
Recent Raise
Eligo Bioscience develops CRISPR-based gene-delivery platforms using bacteriophage capsids and topical vectors to edit microbiome bacteria in situ, creating localized bioreactors for targeted therapeutics across skin microbiomes.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
